Eligible patients reached
Despite its remarkable results, CAR T-cell therapy reaches fewer than about 1 in 5 eligible patients. Geographic, financial, and logistical barriers prevent the majority from ever accessing a treatment that could save their lives.
Source: NEJM / ASH clinical access studies










